2024 Intellia therapeutics stocks

Intellia therapeutics stocks

Author: qqwm

August undefined, 2024

NettetCAMBRIDGE, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on … Nettet21 timer siden · Fintel reports that on April 13, 2024, Canaccord Genuity initiated coverage of Intellia Therapeutics (NASDAQ:NTLA) with a Buy recommendation. As of April 6, 2024, the average one-year price target ...

Vertex, Intellia Therapeutics: Gene Editing Stocks To Watch

Nettet12 timer siden · Are you looking for some growth stocks than can double in value? Two stocks that analysts appear to be bullish on right now are Intellia Therapeutics (NTLA-2.79%) and Rivian Automotive (RIVN-7.20% Nettet21. mar. 2024 · March 21, 2024 - 7:30 am. CAMBRIDGE, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage … good insulators for ice

Intellia Therapeutics - investor relations

Nettet31. mar. 2024 · Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings within the last quarter: In the last 3 months, 13 analysts have offered 12-month price targets for Intellia... Nettet3. jan. 2024 · Intellia has partnered with big biotech Regeneron. CRISPR and Intellia represent major opportunity -- but also significant risk. Motley Fool Issues Rare “All In” Buy Alert NASDAQ: CRSP CRISPR... NettetEXHIBIT 99.1 . Intellia Therapeutics Announces Proposed Public Offering of Common Stock . CAMBRIDGE, Mass., Nov. 30, 2024 (GLOBE NEWSWIRE) – Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex … good insulation materials

Intellia Therapeutics, Inc. (NTLA) - Yahoo Finance

Intellia Therapeutics Shares Soar 12% on Positive Analyst Rating …

Nettet12. apr. 2024 · Intellia Therapeutics Stock Forecast 2030-2034 In this period, the Intellia Therapeutics price would rise from $150.00 to $188.96, which is +26%. Intellia Therapeutics will start 2030 at $150.00, then soar to $153.16 within the first half of the year, and finish 2030 at $156.45. It is about +293% from today. 03/13/2024 Nettet6. apr. 2024 · Intellia Therapeutics, Inc. is a clinical-stage genome editing company, which is focused on developing curative therapeutics using Clustered, Regularly … goodin supply companyNettet28. jun. 2024 · Goldman Sachs analyst Salveen Richter maintained Intellia Therapeutics with a Buy rating and raised the price target from $115 to $163. Barclays analyst Gena Wang maintained Intellia... good insulation for basement ceiling

"Nettet13. apr. 2024 · Nearly 5.59% of Intellia Therapeutics Inc.’s shares belong to company insiders and institutional investors own 80.40% of the company’s shares. The data on … " - Intellia therapeutics stocks

Intellia therapeutics stocks

NettetStock Information - Intellia Therapeutics Stock Information Overview Press Releases Scientific Publications & Presentations Corporate Deck Events & Presentations Press … Nettet14. apr. 2024 · The stock had previously closed at $35.31, but opened at $36.58. Intellia Therapeutics shares last traded at $35.16, with a volume of 86,959 shares trading hands.

Did you know?

NettetThe average NTLA stock price target is $92.40, implying 133.25% upside potential. The Takeaway: NTLA Stock Entices, but be Careful With the development of CRISPR opening the pathway to gene editing, humanity may eventually cure diseases, not just manage them. That’s the potential undergirding NTLA stock. NettetGet the latest Intellia Therapeutics Inc (NTLA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …

Nettet20. mar. 2024 · View the latest Intellia Therapeutics Inc. (NTLA) stock price, news, historical charts, analyst ratings and financial information from WSJ. Nettet11. apr. 2024 · See the latest Intellia Therapeutics Inc stock price (NASDAQ:NTLA), related news, valuation, dividends and more to help you make your investing decisions.

Nettet13. apr. 2024 · Intellia Therapeutics Stock Performance. 3 Mid-Caps That Could Double in 2024; Shares of NTLA opened at $34.58 on Thursday. The stock has a fifty day moving average price of $39.20 and a 200 day moving average price of $43.29. Intellia Therapeutics, Inc. has a 12 month low of $32.44 and a 12 month high of $76.45. Nettet21. mar. 2024 · The Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, and financial analysts. Skip to main navigation About . Who We Are; Core Values ... Stock Information . Data Provided by Refinitiv. Minimum 15 minutes delayed. Press Releases Mar 21, 2024

Nettet13. apr. 2024 · Intellia Therapeutics Stock Performance. Shares of NTLA opened at $34.58 on Thursday. The stock has a fifty day moving average price of $39.20 and a …

Nettet27. des. 2024 · Intellia Therapeutics, Inc. Common Stock (NTLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. goodin supply st paul good insults to say to someoneNettet12. apr. 2024 · 18 analysts have issued 1-year price targets for Intellia Therapeutics' shares. Their NTLA share price forecasts range from $39.00 to $180.00. On average, … good insults to call girlsNettetr/IntelliaTherapeutics: $NTLA Stock Message Board on Reddit. CRISPR technology and stock prices discussion. good insurance claysburg paNettet13. apr. 2024 · Intellia Therapeutics Stock Performance. Shares of NTLA opened at $34.58 on Thursday. The stock has a fifty day moving average price of $39.20 and a 200 day moving average price of $43.29. good insurance companies for home insuranceNettet10. apr. 2024 · Intellia Therapeutics Inc. U.S.: Nasdaq market open $ 34.54 NTLA -1.42 -3.95% Apr 10, 2024 3:19 p.m. EDT Real Time Quote About Intellia Therapeutics Inc. Intellia Therapeutics, Inc. is a... good insurance company namesNettet14. apr. 2024 · The stock had previously closed at $35.31, but opened at $36.58. Intellia Therapeutics shares last traded at $35.16, with a volume of 86,959 shares changing hands. good insurance companies allstate